Percutaneous penetration and absorption of parathion using human and pig skin models in vitro and human skin grafted onto nude mouse skin model in vivo

Journal of Applied Toxicology

Volumn 28, Issue 5, 2008, Pages 645-657

  Boudry, I ^a   Blanck, O ^b   Cruz, C ^a   Blanck, M ^b   Vallet, V ^a   Bazire, A ^a   Capt, A ^b   Josse, D ^a   Lallement, G ^a  

^a Centre de Recherche du Service de Santé des Armées   (France)

^b BAYER AG   (Germany)

Author keywords

Human skin; Human skin grafted onto nude mouse; In vivo in vitro; Organophosphate; Parathion; Percutaneous penetration absorption; Pig skin

Indexed keywords

ACETONE; ALCOHOL; ORGANOPHOSPHATE PESTICIDE; PARATHION;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EAR; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PREDICTION; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN GRAFT; SKIN PENETRATION; SKIN PERMEABILITY; STRATUM CORNEUM; SWINE; TOXICOKINETICS;

ACETONE; ANIMALS; DATA INTERPRETATION, STATISTICAL; ETHANOL; HUMANS; INSECTICIDES; MEMBRANES; MICE; MICE, NUDE; PARATHION; RADIOPHARMACEUTICALS; SKIN; SKIN ABSORPTION; SKIN TRANSPLANTATION; SOLVENTS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS; SUIDAE;

EID: 47549100363     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1317     Document Type: Article

References (83)

1. Amitai G, Dani R, Hershkovitz M, Bel, Rabinovitz I, Meshuman R. 2003. Degradation of VX and sulphur mustard by enzymatic haloperoxidation. J. Appl. Toxicol. 23: 225-233.
2. Archibald BA, Solomon KR, Stephenson GR. 1994. Estimating pirimicarb exposure to greenhouse workers using video imaging. Arch. Environ. Contam. Toxicol. 27: 126-129.
3. Ballantyne B, Marrs TC. 1992. Overview of the biological and clinical aspects of organophosphates and carbamates. In Clinical and Experimental Toxicology of Organophosphates and Carbamates, Ballantyne B, Marrs TC (eds). Butterworth-Heinemann: London; 3-14.
4. Bartech MJ, LaBudde JA, Maibach HI. 1972. Skin permeability in vivo: comparison in rat, rabbit, pig and man. J. Invest. Dermatol. 58: 114-123.
5. Benford DJ, Cocker J, Sartorelli P, Schneider T, Van Hemmen J, Firth G. 1999. Dermal route in systemic exposure. Scand. J. Work Environ. Health 25: 511-520.
6. Braue EH. 1999. Development of reactive topical skin protectant. J. Appl. Toxicol. 19: S47-S53.
7. Brimer L, Gyrd-Hansen N, Rasmussen F. 1994. Disposition of parathion after dermal application in pigs. J. Vet. Pharmacol. Ther. 17: 304-308.
8. Bronaugh RL, Krealing MEK, Yourick JJ. 2005. Determination of percutaneous absorption by in vitro techniques. In Percutaneous Absorption: Drugs-Cosmetics-Mechanisms-Methodology, 4th edn, Bronaugh RL, Maibach HI (eds). Taylor and Francis: Kentucky Distribution Center, USA.
9. Bronaugh RL, Stewart RF, Congdon ER. 1982. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol. Appl. Pharmacol. 62: 481-488.
10. Bronaugh RL, Stewart RF, Simon M. 1986. Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin. J. Pharm. Sci. 75: 1094-1097.
11. Capt A, Luzy AP, Esdaile D, Blanck O. 2007. Comparison of the human skin grafted onto nude mouse model with in vivo and in vitro models in the prediction of percutaneous penetration on three lipophilic pesticides. Regul. Toxicol. Pharmacol. 47: 274-287.
12. Carver MP, Riviere JE. 1989. Percutaneous absorption and excretion of xenobiotics after topical and intravenous administration to pigs. Fundam. Appl. Toxicol. 13: 714-722.
13. Carver MP, Williams PL, Riviere JE. 1989. The isolated perfused porcine skin flap. HI. Percutaneous absorption pharmacokinetics of organophosphates, steroids, benzoic acid and caffeine. Toxicol. Appl. Pharmacol. 97: 324-337.
14. Carver MP, Levi PE, Riviere JE. 1990. Parathion metabolism during percutaneous absorption in perfused porcine skin. Pestic. Biochem. Physiol. 38: 245-254.
15. Chang SK, Riviere JE. 1991. Percutaneous absorption of parathion in vitro in porcine skin: effects of dose, temperature, humidity, and perfusate composition on absorptive flux. Fundam. Appl. Toxicol. 17: 494-504.
16. Chang SK, Riviere JE. 1993. Effect of humidity and occlusion on the percutaneous absorption of parathion in vitro. Pharm. Res. 10: 152-155.
17. Chang SK, Willimans PL, Dauterman WC, Riviere JE. 1994. Percutaneous absorption, dermatopharmacokinetics and related biotransformation studies of carbaryl, lindane malathion and parathion in isolated perfused porcine skin. Toxicology 91: 269-280.
18. Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED, Hamilton MG. 2005a. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig. Basic Clin. Pharmacol. Toxicol. 97: 35-38.
19. Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED, Hamilton MG. 2005b. In vivo absorption and distribution of the nerve agent VX (O-emyl-S-[2(diisopropylamino)ethyl] methylphosphothioate) in the domestic white pig. Hum. Exp. Toxicol. 24: 347-352.
20. Chilcott RP, Dalton CH, Hill I, Davidson CM, Blohm KL, Hamilton MG. 2003. Clinical manifestation of VX poisoning following percutaneous exposure in the domestic white pig. Hum. Exp. Toxicol. 22: 255-261.
21. Craig FN, Cummings EG, Sim VM. 1977. Environmental temperature and the percutaneous absorption of a cholinesterase inhibitor, VX. J. Invest. Dermatol. 68: 357-361.
22. Dalton CH, Hattersley U, Rutter SJ, Chilcott RP. 2006. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro. Toxicol. In Vitro 20: 1532-1536.
23. Demarchez M, Hartmann DJ, Pruniereas M. 1987. An immunohistological study of the revascularization process in human skin transplanted onto the nude mouse. Transplantation 43: 896-903.
24. Dick IP, Scott RC. 1992. Pig ear skin as an in vitro model for human skin permeability. J. Pharm. Pharmacol. 44: 640-645.
25. Dorandeu F, Mikler JR, Thiermann H, Term C, Davidson C, Sawyer TW, Lallement G, Worek F. 2007. Swine model in the design of more effective medical countermeasures against organophosphorus poisoning. Toxicology 233: 128-144.
26. Duncan EJ, Brown A, Lundy P, Sawyer TW, Hamilton M, Hill I, Conley JD. 2002. Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine. J. Appl. Toxicol. 22: 141-148.
27. ECETOC. 1993. Monograph no 20. Percutaneous Absorption, Stringer DA (ed.). ECETOC: Brussels.
28. Feldmann RJ, Maibach HI. 1974. Percutaneous penetration of some pesticides and herbicides in man. Toxicol. Appl. Pharmacol. 28: 126-133.
29. Franz TJ. 1975. Percutaneous absorption on the relevance of in vitro data. J. Invest. Dermatol. 64: 190-195.
30. Fredriksson T, Hansson CH, Holmstedt B. 1960. Effects of sarin in the anesthetized dog following inhalation, percutaneous absorption, and intravenous infusion. Arch. Int. Pharmacodyn. Ther. 126: 288-302.
31. Graig GM, Yardley HJ. 1975. Lipid composition of cells isolated from pig, human, and rat epidermis. J. Lipid Res. 16: 434-440.
32. Gryd-Hansen N, Brimer L, Rasmusen F. 1993. Percutaneous absorption of organophosphorus insecticides in pigs - influence of different vehicles. J. Vet. Pharmacol. Ther. 16: 174-180.
33. Hamilton MG, Hill I, Conley J, Sawyer TW, Caneval DC, Lundy PM. 2004. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination. Mil. Med. 169: 856-862.
34. Hawkins GS Jr, Reifenrath WG. 1984. Development of an in vitro model for determining the fate of chemicals applied to skin. Fundam. Appl. Toxicol. 4: S133-S144.
35. Hawkins GS, Reifenrath WG. 1986. Influence of skin source, penetration cell fluid, and partition coefficient on in vitro skin penetration. J. Pharm. Sci. 75: 378-381.
36. Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH. 2006. Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharm. Res. 23: 1850-1856.
37. Higounec I, Spies F, Bodde H, Schaefer H, Demarchez M, Shroot B, Ponec M. 1994. Lipid composition and barrier function of human skin after grafting onto athymic nude mice. Skin Pharmacol. 7: 167-175.
38. Holbrook KA, Odland GF. 1974. Regional difference in the thickness (cell layers) of the human stratum corneum: an ultrastructural analysis. J. Invest. Dermatol. 62: 415-422.
39. Jacobi U, Kaiser M, Toll R, Mangelsdorf S, Audring H, Otberg N, Sterry W, Ladermann J. 2007. Porcine ear skin: an in vitro model for human skin. Skin Res. Technol. 13: 19-24.
40. Kadar T, Fishbine E, Meshulam J, Sahar R, Amir A, Barness I. 2003. A topical skin protectant against chemical warfare agents. Irs. Med. Assoc. J. 5: 717-719.
41. Kim DD, Kim JL, Chien YW. 1996. Mutual hairless rat skin permeation enhancing effect of ethanol/water system and oleic acid. J Pharm. Sci. 85: 1191-1195.
42. Krueger GG, Wojciechowski ZJ, Burton SA, Gilhar A, Huether SE, Leonard LG, Rohr UD, Petelenz TJ, Higuchi WI, Pershing LK. 1985. The development of a rat/human skin flap served by a defined and accessible vasculature on a congenitally athymic (nude) rat. Fundam. Appl. Toxicol. 5: S112-S121.
43. Liu DK, Wannemacher RW, Snider TH, Hayes TL. 1999. Efficacy of the topical skin protectant in advanced development. J. Appl. Toxicol. 19: S40-S45.
44. Löffler H. Dreher F, Maibach HI. 2004. Stratum corneum adhesive tape stripping: influence of anatomical site, application pressure, duration and removal. Br. J. Dermatol. 151: 746-752.
45. Maibach HI, Feldmann RJ, Milby TH, Serat WF. 1971. Regional variation in percutaneous penetration in man. Pesticides. Arch. Environ. Health 23: 208-211.
46. Marcarian H, Calhoun ML. 1966. Microscopic anatomy of the integument of adult swine. Am. J. Vet. Res. 27: 765-772.
47. Meyer W, Kacza J, Zschemisch NH, Godynicki S, Seeger J. 2007. Observations on the actual structural conditions in the stratum superficial dermidis of porcine ear skin, with special reference to its use as model for human skin. Ann. Anat. 189: 143-156.
48. Meyer W, Schwarz R, Neurand K. 1978. The skin of domestic mammals as a model for the human skin with special reference to the domestic pig. Curr. Probl. Dermatol. 7: 39-52.
49. Monteiro-Riviere NA. 1986. Ultrastructural evaluation of porcine integument. In Swine in Biomedical Research, Tumbleson ME (ed.). Plenum Press: New York; 641-655.
50. Monteiro-Riviere NA, Bristol NA, Manning TO, Rogers RA, Riviere JE. 1990. Interspecies and interregional analysis of the comparative histologic thickness and laser doppler blood flow measurement at five cutaneous sites in nine species. J. Invest. Dermatol. 95: 582-586.
51. OECD. 2004a. Guideline for the testing of chemicals, skin absorption: in vivo method. In OECD Guideline for Testing of Chemicals. Guideline 427.
52. OECD. 2004b. Guideline for the testing of chemicals, skin absorption: in vitro method. In OECD Guideline for Testing of Chemicals. Guideline 428.
53. Petitot F, Moreels AM, Paquet F. 2004. In vitro evaluation of percutaneous diffusion of uranyl nitrate through intact or excoriated skin of rat and pig. Can. J. Physiol. Pharmacol. 82: 133-139.
54. Pinnagoda J, Tupker RA, Agner T, Serup J. 1990. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 22: 164-178.
55. Puga FR, Rodrigues MA. 1996. Evaluation of the role of formulation on parathion toxicity. Ecotoxicol. Environ. Saf. 35: 38-40.
56. Qiao GL, Brooks JD, Baynes RE, Monteiro-Riviere N, Williams PL, Riviere JE. 1996. The use of mechanistically defined chemical mixture (MDCM) to assess mixture component effects on the percutaneous absorption and cutaneous deposition of topically exposed chemicals. I. Studies with parathion mixtures in isolated perfused porcine skin. Toxicol. Appl. Pharmacol. 141: 473-486.
57. 14C] parathion in vivo in pigs. Toxicol. Appl. Pharmacol. 122: 131-138.
58. Qiao GL, Riviere JE. 1995. Significant effects of application site and occlusion on the pharmacokinetics of cutaneous penetration and biotransformation of parathion in vivo in swine. J. Pharm. Sci. 84: 425-432.
59. Qiao GL, Williams PL, Riviere JE. 1994. Percutaneous absorption, biotransformation and systemic disposition of parathion in vivo in swine. Comprehensive pharmacokinetic model. Drug Metab. Dispos. 22: 459-471.
60. Reifenrath WG, Chellquist EM, Shipwash EA, Jederberg WW, Krueger GG. 1984. Percutaneous penetration in the hairless dog, weanling pig and grafted athymic nude mouse: evaluation of models for predicting skin penetration in man. Br. J. Dermatol. 111: 123-135.
61. Reifenrath WG, Hawkins GS, Kurtz MS. 1991. Percutaneous penetration and skin retention of topically applied compounds: an in vitro-in vivo study. J. Pharm. Sci. 80: 526-532.
62. Riviere JE, Bowman KF, Monteiro-Riviere NA, Carver MP, Dix LP. 1986. The isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies. Fundam. Appl. Toxicol. 7: 444-453.
63. Riviere JE, Monteiro-Riviere NA. 1991. The isolated perfused porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology. Crit. Rev. Toxicol. 21: 329-344.
64. Romano JA, Filbert MG. 1999. Historical overview of topical skin protectant development. J. Appl. Toxicol. 1: S39.
65. Rosado C, Cross SE, Pugh WJ, Roberts MS, Hadgraft J. 2003. Effect of vehicle pretreatment on the flux, retention, and diffusion of topically applied penetrants in vitro. Pharm. Res. 20: 1502-1507.
66. Scott RC, Corrigan MA, Smith F, Mason H. 1991. The influence of skin structure on permeability: an intersite and interspecies comparison with hydrophilic penetrants. J. Invest. Dermatol. 96: 921-925.
67. Scott R, Rhodes C. 1987. The permeability of grafted transplant skin in athymic mice. J. Pharm. Pharmacol. 40: 128-129.
68. Shehata-Karam H, Monteiro-Riviere NA, Guthrie FE. 1988. In vitro penetration of pesticides through human newborn foreskin. Toxicol. Lett. 40: 233-239.
69. Simon GA, Maibach HI. 2000. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations - an overview. Skin Pharmacol. Appl. Skin Physiol. 13: 229-234.
70. Southwell D, Barry BW, Woodford R. 1984. Variations in permeability of human skin within and between specimens. Int. J. Pharm. 18: 299-309.
71. Spencer PS, Bischoff MC. 1983. Skin as a route of entry for neurotoxic substances. In Dermatotoxicology, 2nd edn, Marzulli FN, Maibach HI (eds). Hemisphere: Washington; 611-626.
72. Tregear RT. 1966. Molecular movement, the permeability of the skin. In Physical Functions of Skin. Academic Press: New York; 1-52.
73. Vallet V, Cruz C, Josse D, Bazire A, Lallement G, Boudry I. 2007. In vitro percutaneous penetration of organophosphorus compounds using full-thickness and split-thickness pig and human skin. Toxicol. In Vitro. (in press, doi/10.1016/j.tiv.2007.03.07).
74. Van der Merwe D, Brooks JD, Gehring R, Baynes RE, Monteiro-Riviere NA, Riviere JE. 2006. A physiologically based pharmacokinetic model of organophosphate dermal absorption. Toxicol. Sci. 89: 188-204.
75. Van der Merwe D, Riviere JE. 2005. Comparative studies on the effects of water, ethanol and water/ethanol mixtures on chemical partitioning into porcine stratum corneum and silastic membrane. Toxicol. In Vitro 19: 69-77.
76. Van der Schans MJ, Lander BJ, Vander Wiel H, Langenberg JP, Benschop HP. 2003. Toxicokinetics of the nerve agent (+/-) VX in anesthetized and atropinized hairless guinea pigs and marmosetsafter intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 191: 48-62.
77. Van Genderen JV, Mol MAE, Wolthius OL. 1985. On the development of skin models for toxicity testing. Fundam Appl Toxicol. 5: S98-S111.
78. Van Hooidonk C, Ceulen BI, Kienhuis H, Bock J. 1980. Rate of skin penetration of organophosphates measured in diffusion cells. Dev. Toxicol. Environ. Sci. 8: 643-646.
79. Wester RC, Melendres J, Sedik L, Maibach HI, Riviere JE. 1998. Percutaneous absorption of salicylic acid, theophylline, 2, 4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo. Toxicol. Appl. Pharmacol. 151: 159-165.
80. Wester RM, Tanojo H, Maibach HI, Wester RC. 2000. Predicted chemical warfare agent VX toxicity to uniformed soldier using parathion in vitro human skin exposure and absorption. Toxicol. Appl. Pharmacol. 168: 149-152.
81. Williams FM. 2006. In vitro studies - How good they are replacing in vivo studies for measurement of skin absorption. Environ. Toxicol. Pharmacol. 21: 199-203.
82. Yanagisawa N, Morita H, Nakajima T. 2006. Sarin experiences in Japan: acute toxicity and long-term effects. J. Neurol. Sci. 249: 76-85.
83. Yourick JJ, Koenig ML, Yourick DL, Bronaugh RL. 2004. Fate of chemicals in skin after dermal application: does the in vitro skin reservoir affect the estimate of systemic absorption? Toxicol. Appl. Pharmacol. 195: 309-320.